Lucid Diagnostics (LUCD) Net Cash Flow (2020 - 2026)

Lucid Diagnostics has reported Net Cash Flow for 7 years, with the latest figure at -$6.8 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 337.12% year-over-year to -$6.8 million; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (up 459.28% YoY), and the FY2025 full-year result was $12.3 million, up 256.21% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$6.8 million, up from -$12.6 million in the prior quarter.
• The five-year high for Net Cash Flow was $17.0 million in Q1 2023, with the low at -$15.2 million in Q2 2022.
• Historically, Net Cash Flow has averaged -$1.5 million across 5 years, with a median of -$5.2 million in 2023.
• Annual changes were most pronounced in 2022 — Net Cash Flow plunged 23804.17% — and 2025, when it surged 3797.35%.
• Lucid Diagnostics' Net Cash Flow stood at -$4.5 million in 2022, then dropped by 15.56% to -$5.2 million in 2023, then surged by 252.68% to $7.9 million in 2024, then sank by 260.66% to -$12.6 million in 2025, then surged by 45.98% to -$6.8 million in 2026.
• The last three Net Cash Flow figures came in at -$6.8 million (Q1 2026), -$12.6 million (Q4 2025), and $16.2 million (Q3 2025), per Business Quant data.